BIOMAT Database Logo BIOMAT Database Logo

Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy. 1991

G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Neoadjuvant or adjuvant chemotherapy in early breast cancer?
June 2020, Expert opinion on pharmacotherapy,
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
June 2005, Gynakologisch-geburtshilfliche Rundschau,
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy.
January 2021, Cancer journal (Sudbury, Mass.),
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment.
January 2013, Breast cancer (Tokyo, Japan),
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
[Adjuvant treatment of breast cancer. Endocrine therapy].
September 2007, Ugeskrift for laeger,
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach.
May 2015, Seminars in oncology nursing,
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
[Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
April 1982, Revue medicale de Bruxelles,
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer.
May 2023, American journal of surgery,
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Endocrine therapy as adjuvant or neoadjuvant therapy for breast cancer: selecting the best agents, the timing and duration of treatment.
June 2016, Chinese clinical oncology,
G Bonadonna, and P Valagussa, and C Brambilla, and A Moliterni, and M Zambetti, and L Ferrari
Emerging modalities for adjuvant therapy of breast cancer: neoadjuvant chemotherapy.
January 1986, NCI monographs : a publication of the National Cancer Institute,
Copied contents to your clipboard!